APA (7th ed.) Citation

S, R., J, F., E, B., E, V. G., MJ, C., D, L., & C, R. (2007). Cost-effectiveness of raising HDL cholesterol by adding prolonged-release nicotinic acid to statin therapy in the secondary prevention setting: A French perspective. International journal of clinical practice, 61(11), 1805. https://doi.org/10.1111/j.1742-1241.2007.01546..x

Chicago Style (17th ed.) Citation

S, Roze, Ferrières J, Bruckert E, Van Ganse E, Chapman MJ, Liens D, and Renaudin C. "Cost-effectiveness of Raising HDL Cholesterol by Adding Prolonged-release Nicotinic Acid to Statin Therapy in the Secondary Prevention Setting: A French Perspective." International Journal of Clinical Practice 61, no. 11 (2007): 1805. https://doi.org/10.1111/j.1742-1241.2007.01546..x.

MLA (9th ed.) Citation

S, Roze, et al. "Cost-effectiveness of Raising HDL Cholesterol by Adding Prolonged-release Nicotinic Acid to Statin Therapy in the Secondary Prevention Setting: A French Perspective." International Journal of Clinical Practice, vol. 61, no. 11, 2007, p. 1805, https://doi.org/10.1111/j.1742-1241.2007.01546..x.